Medpace Holdings Inc. share price logo

Medpace Holdings Inc.

NASDAQ: MEDP

Large Cap

$460.20

+3.11

(+0.68%)

as on

Medpace Holdings Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $447.95
    $461.23
    downward going graph

    2.66%

    Downside

    0.22%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $301.90
    $628.92
    downward going graph

    34.40%

    Downside

    36.66%

    Upside

    downward going graph

Medpace Holdings Inc. share price movements today

Previous Close
$457.09
Open
$460.08
Volume
183.0K
Day's Low - High
$447.95 - $461.23
52 Week Low - High
$301.90 - $628.92

Medpace Holdings Inc. Historical Returns

1 Month Return
+ 9.59 %
3 Month Return
-0.16 %
1 Year Return
+ 52.04 %
3 Year Return
+ 107.47 %
5 Year Return
+ 159.21 %

Medpace Holdings Inc. Stock Fundamentals & Key Indicators

Check Medpace Holdings Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.1B

EPS (TTM)

17.0648

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.17%

PE Ratio (TTM)

28.96

Industry PE ratio

9.453333333333333

PEG Ratio

2.814

EBITDA

591.0M

Revenue (TTM)

2.7B

Profit Margin

17.19%

Return On Equity TTM

77.25%

Medpace Holdings Inc. Stock Valuation

Track how Medpace Holdings Inc. P/E has moved over time to understand its valuation trends.

Medpace Holdings Inc. in the last 5 years

  • Overview

  • Trends

Lowest (22.30x)

June 30, 2025

Industry (9.45x)

June 19, 2026

Today (28.96x)

June 19, 2026

Highest (42.65x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 28.96x

Medpace Holdings Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Medpace Holdings Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$13.1B159.21%28.9617.19%NA
BUY$43.1B-6.48%40.2124.63%NA
BUY$35.1B-12.38%24.9719.55%0.7799999999999999%
BUY$171.6B-3.7%25.3715.15%0.37%
BUY$125.8B-31.05%34.3814.89%0.75%

Stock Returns calculator for Medpace Holdings Inc. Stock including INR - Dollar returns

The Medpace Holdings Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Medpace Holdings Inc. investment value today

Current value as on today

₹1,65,114

Returns

₹65,114

(+65.11%)

Returns from Medpace Holdings Inc. Stock

₹52,037 (+52.04%)

Dollar Impact

₹13,077 (+13.08%)

Analyst Recommendation on Medpace Holdings Inc. Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Medpace Holdings Inc.. Average target price of $442.83

Medpace Holdings Inc. Share Price Target

Get share price movements and forecasts by analysts on Medpace Holdings Inc..

What analysts predicted

-3.92%DOWNSIDE

Target Price

$442.83

Current Price

$460.2

Analyzed by

12 Analysts

Target

$442.83

Medpace Holdings Inc. target price $442.83, a slight downside of -3.92% compared to current price of $460.2. According to 12 analysts rating.

Indian Investors' Interest in Medpace Holdings Inc. Stock

Search interest for Medpace Holdings Inc. Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Medpace Holdings Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
498
511
528
533
536
558
603
659
708
706
Gross Profit
136
155
153
169
178
178
180
196
205
196
Operating Income
87
104
105
112
125
113
126
141
153
141
EBITDA
96
119
117
126
141
125
131
149
163
154
Interest Expense
1
4
5
7
7
-
-
-
-
-
Depreciation
6
6
7
7
7
6
7
7
7
6
Income Before Tax
90
112
110
118
133
118
124
142
156
147
Income Tax Expense
12
10
22
22
16
3
34
31
21
23
Net Income
78
102
88
96
117
114
90
111
135
123
Net Profit Margin
15.71%
20.07%
16.73%
18.08%
21.81%
20.52%
14.96%
16.84%
19.07%
17.53%

Medpace Holdings Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
421
436
704
860
925
1,142
1,459
1,885
2,109
2,530
Gross Profit
172
174
215
245
278
328
432
524
656
760
Operating Income
52
64
101
127
167
198
278
336
446
534
EBITDA
99
110
139
150
186
223
308
362
505
570
Interest Expense
19
7
8
1
0
0
2
0
24
-
Depreciation
-
46
38
23
19
21
22
25
29
28
Income Before Tax
21
56
93
124
168
201
282
335
475
542
Income Tax Expense
8
17
20
24
23
20
37
52
71
91
Net Income
13
39
73
100
145
181
245
282
404
451
Net Profit Margin
3.18%
8.97%
10.39%
11.67%
15.70%
15.92%
16.81%
15.00%
19.17%
17.83%

Medpace Holdings Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
102
88
96
117
114
90
111
135
123
Operating Cash Flow
152
116
149
190
125
148
246
192
151
Investing Cash Flow
2
-12
-10
-7
-9
-6
-10
-4
-6
Financing Cash Flow
7
0
6
-168
-345
-540
3
22
12
Change in Cash
161
103
146
12
-228
-395
239
211
155

Medpace Holdings Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
39
73
100
145
181
245
282
404
451
Operating Cash Flow
97
156
201
258
263
388
433
608
713
Investing Cash Flow
-12
-16
-19
-31
-31
-38
-34
-28
-31
Financing Cash Flow
-97
-141
-73
-82
-44
-775
-182
-154
-860
Change in Cash
-10
-3
108
145
183
-433
217
423
-172

Global Institutional Holdings in Medpace Holdings Inc.

Funds
Holdings
Wasatch Advisors LP
2.71%
D. E. Shaw & Co LP
1.51%
Millennium Management LLC
1.23%
Northern Trust Corp
1.2%
Arrowstreet Capital Limited Partnership
1.39%

Medpace Holdings Inc. News & Key Events

  • img

    Today's Timeline - 20 November

    Thu, 07:46 PM

    -

    Medpace reports Q3 2025 EPS of $3.86, exceeding estimates by 10.29%; revenues of $659.9 million also beat expectations.

Insights on Medpace Holdings Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MEDP has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MEDP has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, MEDP stock has moved up by 104.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 135.13M → 123.87M (in $), with an average decrease of 8.3% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 708.45M → 706.60M (in $), with an average decrease of 0.3% per quarter

About Medpace Holdings Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
OrganisationMedpace Holdings Inc.
Headquarters5375 Medpace Way, Cincinnati, OH, United States, 45227
IndustryDiagnostics & Research
CEODr. August James Troendle M.D.
E-voting on sharesClick here to vote

Key Management of Medpace Holdings Inc.

Name

Title

Dr. August James Troendle M.D.

CEO, President & Chairman

Mr. Brad W. Hansman

Executive Vice President of Operations

Mr. Todd Meyers

Vice President of Business Development & Marketing

Mr. Kevin M. Brady

CFO & Treasurer

Mr. Stephen P. Ewald J.D.

Chief Compliance Officer, General Counsel & Corporate Secretary

Ms. Lauren Morris

Associate Director of Investors Relations

Mr. Weimin Gai MS

Senior Vice President of Biometrics

Mr. John T. Wynne MBA

Senior Vice President of Commercial Operations & Clinical Pharmacology Unit

Ms. Reinilde Heyrman M.D.

Chief Medical Officer of Medical Department

Ms. Gina Leisring M.P.H.

Senior Vice President of Clinical Monitoring

FAQs

What is Medpace Holdings Inc. share price today?

Medpace Holdings Inc. share price today is $460.2 as on at the close of the market. Medpace Holdings Inc. share today touched a day high of $461.23 and a low of $447.95.

What is the 52 week high and 52 week low for Medpace Holdings Inc. share?

Medpace Holdings Inc. share touched a 52 week high of $628.92 on and a 52 week low of $301.9 on . Medpace Holdings Inc. stock price today i.e. is closed at $460.2,which is 26.83% down from its 52 week high and 52.43% up from its 52 week low.

What is Medpace Holdings Inc.'s market capitalisation today?

Medpace Holdings Inc. market capitalisation is $0.01T as on .

How to invest in Medpace Holdings Inc. Stock (MEDP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Medpace Holdings Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Medpace Holdings Inc. Shares that will get you 0.0033 shares as per Medpace Holdings Inc. share price of $460.2 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Medpace Holdings Inc. Stock (MEDP) from India?

Indian investors can start investing in Medpace Holdings Inc. (MEDP) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Medpace Holdings Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Medpace Holdings Inc. share’s latest price of $460.2 as on June 19, 2026 at 8:45 am IST, you will get 0.0217 shares of Medpace Holdings Inc.. Learn more about fractional shares .

What are the returns that Medpace Holdings Inc. has given to Indian investors in the last 5 years?

Medpace Holdings Inc. stock has given 159.21% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?